SALT LAKE CITY, July 11, 2012 (GLOBE NEWSWIRE) -- Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world's fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced its participation in the 2012 American Association for Clinical Chemistry (AACC) Annual Meeting taking place July 15-19, in Los Angeles, Calif. Additionally, Seattle Children's Hospital and University of Washington, Seattle, will present data highlighting the utility of the FilmArray Respiratory Panel (FilmArray RP) in the core hospital laboratory. Idaho Technology will also have an exhibition booth (#3030) where company representatives will showcase the FilmArray diagnostic platform.
Poster Session: Infectious Diseases, Thursday, July 19, 9:30 am – 12:00 pm
Title: Implementation of FilmArray Respiratory Viral Panel in a Core Laboratory Improves Testing Turn-Around-Time and Patient Care
Authors: M. Xu, X. Qin, M. L. Astion, J. C. Rutledge, J. Simpson, K. R. Jerome, J. A. Englund, D. Zerr, R. Migita, S. Rich, J. C. Childs, A. Cent, M. A. Del Beccaro
Poster: # E-106
Time: 9:30 am – 12:00 pm
About FilmArray RP
FilmArray RP is Idaho Technology's first clinical diagnostic test designed to run on the Company's novel FilmArray system, which represents a significant advancement in user-friendliness and multiplex infectious disease testing capability for hospital clinical labs. FilmArray RP rapidly detects nucleic acids in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. Requiring only two minutes of hands-on time, FilmArray RP has about a 1-hour turnaround time, and simultaneously tests for the following panel of respiratory pathogens: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Human Metapneumovirus, Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype H1 2009, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. FilmArray RP has received FDA-clearance for twenty targets and is available for use by hospital and clinical laboratory professionals in the United States. In addition, the European version of FilmArray RP is CE IVD marked for twenty-one targets. Idaho Technology is continuing to develop a broader test menu for its FilmArray system, including a blood culture ID panel, gastrointestinal panel, and a meningitis panel.
About Idaho Technology, Inc.
Idaho Technology, Inc. is a privately held clinical diagnostics company based in Salt Lake City, Utah. Founded in 1990, the Company currently holds over 70 patents related to polymerase chain reaction (PCR), including rapid PCR cycling. The Company has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research and military markets. The Company manufactures and distributes its proprietary diagnostic respiratory panel, FilmArray RP, which operates on its user-friendly FilmArray system, to hospital-based clinical laboratories in the U.S. and E.U. The Company also collaborates with various U.S. governmental agencies including the Department of Health and Human Services, and the Department of Defense. Among others, researchers, medical technicians, law enforcement officers, and soldiers in the field use company devices to detect or study disease-causing organisms. For further information, please visit www.idahotech.com.
The Idaho Technology, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13194